Company Overview

Update
Founded:
2012
Founders:
Robert S. Langer, Omid Farokhzad, Stephen J. Lippard
Headquarters:
Watertown, MA
Funding:
$24.80M

Blend Therapeutics operates Maestro™ platform, which designs drugs to target distinct disease pathways safely and efficiently.

Description

Update

Blend is discovering and developing integrative combination medicines with the unprecedented ability to precisely control each agent’s therapeutic action in concert. Using their proprietary Maestro™ platform, they design and integrate drugs to target distinct disease pathways with optimal efficacy and safety. Blend was founded by three leaders in the fields of chemistry and nanomedicine from MIT and Harvard Medical School: Dr. Robert Langer and Dr. Stephen Lippard of MIT, and Dr. Omid Farokhzad of Harvard Medical School.

Current Team (8)

Update

Board Members and Advisors (4)

Update

Funding Rounds (3) - $24.80M

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    134 Coolidge Avenue

    Watertown, MA 02472

    USA

Images (1)

Update
  • 0c5659111d5f15a349c4e8538feb2fbf